I bought in a few weeks ago because I read about them partnering with Novo Nordisk to sell actual FDA-approved Wegovy instead of just the compounded stuff. It sounds like a massive upgrade for their business, but I’m seeing some articles saying their profit might actually drop this quarter because of the costs of transitioning their customers over.
I’ve also seen people throwing around that the short interest is over 30%, which I think means a lot of people are betting against it? I’m genuinely not sure if I should hold my shares through the earnings report tonight or just sell now while I am in the green.
Would really appreciate some insight from people who have been holding this one long-term. Does the Novo Nordisk deal make this a safe hold, or are we expecting a big drop tomorrow?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
244
Report
Login to post
you can get good entries and mentorship from her